Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

13.58

-0.42

(-3.00%)

At close: 04:00PM EDT

13.57

-0.01

(-0.07%)

After hours:

07:41PM EDT

Loading interactive chart...

GuruFocus.com
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
Revenue Beats Estimates, Losses Widen as Company Advances Brain Health Portfolio
Zacks
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
Sage Therapeutics (SAGE) delivered earnings and revenue surprises of -10.43% and 28.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
CAMBRIDGE, Mass., April 25, 2024--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024.